Controlled trial of ornithine alpha ketoglutarate (OAKG) in patients with stroke.
- 1 May 1978
- journal article
- research article
- Published by Wolters Kluwer Health in Stroke
- Vol. 9 (3), 218-222
- https://doi.org/10.1161/01.str.9.3.218
Abstract
A double blind controlled trial of ornithine .alpha.-ketoglutarate (OAKG) was carried out on 50 patients suffering from a recent stroke. Significant improvement was found in patients treated with OAKG when examined on the 5th day of therapy as compared to their control cases. The therapy was given for 5 days. When the patients in the treated and the control groups were compared 10 days after the beginning of treatment, there were no differences between the 2 groups. Implications of these findings are discussed.This publication has 6 references indexed in Scilit:
- Predicting the outcome of stroke: acute stage after cerebral infarction.BMJ, 1975
- Effect of ornithine alpha oxoglutarate on brain metabolism in patients with chronic liver disease.Journal of Neurology, Neurosurgery & Psychiatry, 1975
- Influence of complete ischemia on glycolytic metabolites, citric acid cycle intermediates, and associated amino acids in the rat cerebral cortexBrain Research, 1974
- Effect of ammonium salts on brain metabolismJournal of Neurology, Neurosurgery & Psychiatry, 1974
- Effect of ornithine alpha ketoglutarate on disturbances of brain metabolism caused by high blood ammoniaGut, 1972
- Blood Brain Barrier Permeability to LactateEuropean Neurology, 1971